In addition, some genes appear to be specially chosen at relapse. For instance, small clones harboring TP53 mutations typically expand and dominate the illness right after CIT, which describes the inadequate prognosis linked to these subclonal mutations.12,62 Apart from TP53, mutations in IKZF3 and SAMHD1 have also been recurrently picked in smalle